Results 11 to 20 of about 123,214 (256)
ESC Heart Failure, 2023 Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF]
Mayu Tochiya +11 more
doaj +1 more source
Advanced heart failure with reduced ejection fraction [PDF]
Baylor University Medical Center Proceedings, 2020 Patients suffering advanced heart failure with reduced ejection fraction (HFrEF) account for a large portion of patients admitted to hospitals worldwide. Mortality and 30-day readmission rates for HFrEF are now a focus of value-based payment models, making management of this disease a priority for hospitals, physicians, and payers alike.
Albert Hicks +5 more
openaire +2 more sources
Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
Frontiers in Cardiovascular Medicine, 2021 This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu +8 more
doaj +1 more source
Indian Pacing and Electrophysiology Journal, 2022 Background: This review aims to determine if patients who undergo atrial fibrillation (AF) ablation with heart failure with preserved ejection fraction (HFpEF) do better, or worse or the same compared to patients with heart failure with reduced ejection ...
Gaurav Panchal +4 more
doaj +1 more source
ESC Heart Failure, 2022 Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF) patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF).
Shiqun Chen +15 more
doaj +1 more source
Biomolecules, 2022 Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the heart that gradually result in reduced cardiac output (HFrEF) and/or increased cardiac pressures at rest and under stress (HFpEF).
Federico Ferro +3 more
doaj +1 more source
Cells, 2022 Recent studies have shown that circulating levels of irisin are prognostic factors in heart failure (HF), but no data are available on the predictive role of irisin in patients with type 2 diabetes mellitus (T2DM) and different phenotypes of HF.
Alexander A. Berezin +4 more
doaj +1 more source
The Treatment of Heart Failure with Reduced Ejection Fraction
Deutsches Ärzteblatt international, 2020 Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.This review is based on articles retrieved by a selective search in PubMed, as well as on relevant guidelines.Evidence-based treatment options are available only for ...
Dominik, Berliner +2 more
openaire +3 more sources
Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
Biomolecules, 2020 Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti +14 more
doaj +1 more source
Chronic heart failure with reduced ejection fraction [PDF]
Canadian Medical Association Journal, 2014 See also page [510][1] and [www.cmaj.ca/lookup/doi/10.1503/cmaj.131742][2] Heart failure with reduced ejection fraction is a clinical syndrome of dyspnea, exercise intolerance and/or edema resulting from an impairment of ejection of blood, usually documented by a left ventricular ejection ...
Yasbanoo, Moayedi, Jeremy, Kobulnik
openaire +2 more sources